Position in PROCF
as of Dec 31, 2024
· filed Feb 13, 2025
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
14 quarters on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2025PROEQUITIES, INC. holds $0 across 82 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIK |
Anika Therapeutics, Inc.
|
0 | $0 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
0 | $0 | |
| 3 | INCR |
Intercure Ltd.
|
0 | $0 | |
| 4 | RGC |
Regencell Bioscience Holdings Ltd
|
0 | $0 | |
| 5 | EVO |
Evotec SE
|
0 | $0 | |
| 6 | INM |
InMed Pharmaceuticals Inc.
|
0 | $0 | |
| 7 | SNOA |
Sonoma Pharmaceuticals, Inc.
|
0 | $0 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
0 | $0 |
All Filings in PROCF
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-12-31 PROC | — | 0 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 PROC | — | 0 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 PROC | — | 0 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 PROC | — | 0 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 PROC | — | 0 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 PROC | — | 0 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 PROC | — | 0 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 PROC | — | 0 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 PROC | — | 0 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 PROC | — | 0 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 PROC | — | 0 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 PROC | — | 0 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 PROC | — | 0 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 PROC | — | 0 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||